Matthias Bodenstedt

Companies

• MoonLake ImmunotherapeuticsChief financial officer Apr 15, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MIMoonLake Immunotherapeutics MLTX1,115,435 shares²$10.8M at $9.72Jun 22, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 22, 2026Sold 39,120 shares at $22.04 of MoonLake Immunotherapeutics²
• Jun 18, 2026Sold 2,794 shares at $19.60 of MoonLake Immunotherapeutics³
• Jun 17, 2026Sold 15,082 shares at $19.68 of MoonLake Immunotherapeutics³
• May 11, 2026Sold 13,653 shares at $20.02 of MoonLake Immunotherapeutics⁴
• Apr 14, 2026Sold 2,426 shares at $19.56 of MoonLake Immunotherapeutics⁵
• Apr 10, 2026Sold 1,925 shares at $19.51 of MoonLake Immunotherapeutics⁶
• Apr 9, 2026Sold 85,870 shares at $18.94 of MoonLake Immunotherapeutics⁶
• Jan 7, 2026Granted 354,296 shares of MoonLake Immunotherapeutics⁷
• Dec 19, 2025Returned to company 294,473 shares of MoonLake Immunotherapeutics⁸
• Dec 19, 2025Converted 294,473 shares of MoonLake Immunotherapeutics⁸
• Oct 8, 2025Bought 10,870 shares at $9.09 of MoonLake Immunotherapeutics⁹
• Feb 27, 2025Granted 95,763 shares of MoonLake Immunotherapeutics¹⁰
• Dec 20, 2023Sold 5,264 shares at $58.34 of MoonLake Immunotherapeutics¹¹
• Dec 19, 2023Sold 94,736 shares at $59.22 of MoonLake Immunotherapeutics¹¹
• Oct 1, 2023Returned to company 62,972 shares of MoonLake Immunotherapeutics¹²
• Oct 1, 2023Converted 62,972 shares of MoonLake Immunotherapeutics¹²
• Apr 5, 2023Returned to company 147,135 shares of MoonLake Immunotherapeutics¹³
• Apr 5, 2023Converted 147,135 shares of MoonLake Immunotherapeutics¹³
• Apr 5, 2023Returned to company 410,796 shares of MoonLake Immunotherapeutics¹³
• Apr 5, 2023Converted 410,796 shares of MoonLake Immunotherapeutics¹³